| Authors: |
Chang J; Biotech Research and Innovation Centre (BRIC), University of Copenhagen (UCPH), Copenhagen, Denmark., Lucas MC; The Garvan Institute of Medical Research and The Kinghorn Cancer Centre, Cancer Division, St Vincent's Clinical School, Faculty of Medicine, University of New South Wales, Sydney, Australia., Leonte LE; Biotech Research and Innovation Centre (BRIC), University of Copenhagen (UCPH), Copenhagen, Denmark., Garcia-Montolio M; Biotech Research and Innovation Centre (BRIC), University of Copenhagen (UCPH), Copenhagen, Denmark., Singh LB; Biotech Research and Innovation Centre (BRIC), University of Copenhagen (UCPH), Copenhagen, Denmark., Findlay AD; Pharmaxis Pharmaceutical Ltd., Frenchs Forest, Australia., Deodhar M; Pharmaxis Pharmaceutical Ltd., Frenchs Forest, Australia., Foot JS; Pharmaxis Pharmaceutical Ltd., Frenchs Forest, Australia., Jarolimek W; Pharmaxis Pharmaceutical Ltd., Frenchs Forest, Australia., Timpson P; The Garvan Institute of Medical Research and The Kinghorn Cancer Centre, Cancer Division, St Vincent's Clinical School, Faculty of Medicine, University of New South Wales, Sydney, Australia., Erler JT; Biotech Research and Innovation Centre (BRIC), University of Copenhagen (UCPH), Copenhagen, Denmark., Cox TR; Biotech Research and Innovation Centre (BRIC), University of Copenhagen (UCPH), Copenhagen, Denmark.; The Garvan Institute of Medical Research and The Kinghorn Cancer Centre, Cancer Division, St Vincent's Clinical School, Faculty of Medicine, University of New South Wales, Sydney, Australia. |
